Concepedia
Statistics
Publications
32
Citations
2.6K
H-Index
23
Active since
1997
Affiliations
Pfizer (United States)(Current)
Pfizer (France)
University of Colorado Denver
Wright-Patterson Air Force Base
Cleveland Clinic
Richat Abbas is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.
Publications per year
1997–2019
Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
Harold J. Burstein, Yan Sun, Luc Dirix et al. · Journal of Clinical Oncology · 2010 · 527 citations · Full text
Medicine, Oncology, Pharmacology +17
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Jörge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf et al. · Blood · 2011 · 461 citations
Life Sciences, Hematology, Oncology +9
A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors
Kwok-K. Wong, Paula M. Fracasso, Ronald M. Bukowski et al. · Clinical Cancer Research · 2009 · 303 citations · Full text
Medicine, Oncology, Pharmacology +13
Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2–Dependent and Other Solid Tumors
Leena Gandhi, Rastislav Bahleda, Sara M. Tolaney et al. · Journal of Clinical Oncology · 2013 · 199 citations
Pharmacy, Oncology, Pharmacology +17
A Human Physiologically Based Pharmacokinetic Model for Trichloroethylene and Its Metabolites, Trichloroacetic Acid and Free Trichloroethanol
Jeffrey W. Fisher, Deirdre A. Mahle, Richat Abbas · Toxicology and Applied Pharmacology · 1998 · 118 citations
Pharmacy, Pharmacokinetics, Pharmacology +10
1–5 of 32